Effect of Tongmai Liquid on ET,IL-1 8 and M-CSF in patients with coronary heart disease
- VernacularTitle:通脉液对冠状动脉粥样硬化性心脏病患者血清ET、IL-18、M-CSF的影响
- Author:
Dachuang ZHANG
;
Luyi LUO
;
Jianming YIN
;
Weibin ZHANG
;
Mengyu HUANG
;
Shanshan ZHAO
- Publication Type:Journal Article
- Keywords:
Tongmai Liquid;
CHD;
ET;
IL-18;
M-CSF
- From:
Chinese Traditional Patent Medicine
2010;(1):16-18
- CountryChina
- Language:Chinese
-
Abstract:
AIM:To observe the effect ofTongmai Liquid on endothelin(ET),interlenkin-18(IL-18),macrophage colony stimulating factor(M-CSF)in patients with coronary heart disease(CHD).METHODS:Eighty patients with coronary heart disease accompanied by heart and spleen qi deficiency and qi stagnanty+phlegm stasis and were randomly assigned into test group and control groups.Forty patients in test group were treated with Tongmai Liquid,30 mL,thrice per day,Forty patients in control group were treated with Shexiang Baoxin Pills,2 pills every time,thrice per day.The therapeutic course for both groups was 30 days.The blood-serum ET,IL-18 and M-CSF had been tested before and after the treatment.RESULTS:The levels of blood-serum ET,IL-18 and MCSF in the two groups decreased significantly after treatment(P＜0.05).There's significant difference in two groups'blood-serum of ET(P＜0.05),There're no significant diffference in two groups'blood-serum level IL-18 and of M-CSF(P＞0.05).CONCLUSION:Tongmai Liquid may decrease blood-serum level of ET,IL-18 and M-CSF in patients with coronary heart disease without side effect.
